Log on / register
Feedback | Support | My details

Pre-publication history

Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling. A bone chamber study in rats

Jörgen Åstrand email, Anna Kajsa Harding email, Per Aspenberg email and Magnus Tägil email

BMC Musculoskeletal Disorders 2006, 7:63doi:10.1186/1471-2474-7-63

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript13 Mar 2006
Reviewer's ReportBrigitte von Rechenberg15 Apr 2006
Reviewer's ReportDominique Pioletti20 Apr 2006
Resubmission - Version 2ManuscriptAuthors' comments03 Jun 2006
Reviewer's ReportDominique Pioletti23 Jun 2006
Reviewer's ReportBrigitte von Rechenberg03 Jul 2006
Resubmission - Version 3ManuscriptAuthors' comments01 Aug 2006
Accepted04 Aug 2006
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.